PeterLClarkMD

PubMed

• Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol.
  Wang, L.,Smith, J.,Breton, C.,Clark, P.,Zhang, J.,Ying, L.,Che, Y.,Lape, J.,Bell, P.,Calcedo, R.,Buza, E. L.,Saveliev, A.,Bartsevich, V. V.,He, Z.,White, J.,Li, M.,Jan...> ;Nat. Biotechnol.. 2018 Jul 10
• 53 citations
  Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.
  Conti, D. V., Conti, D. V., Wang, K., Wang, K., Sheng, X., Sheng, X., Bensen, J. T., Bensen, J. T., Hazelett, D. J., Hazelett, D. J., Cook, M. B., Cook, M. B., Ingles,...> ;Journal of the National Cancer Institute.
• 1 citations
  Novel Simulation Model of Non-Muscle Invasive Bladder Cancer: A Platform for a Virtual Randomized Trial of Conservative Therapy vs. Cystectomy in BCG Refractory Patients.
  Patel, S., Dinh, T., Noah-Vanhoucke, J., Rengarajan, B., Mayo, K., Clark, P. E., Kamat, A. M., Lee, C. T., Sexton, W. J., Steinberg, G. D.> ;Bladder cancer (Amsterdam, Netherlands).
• 1 citations
  Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma.
  Clark, P. E.> ;Biologics : targets & therapy.
• Join now to see all